SCHEMBL21881920

SCHEMBL21881920

CP(C)(=O)c1cccc(-c2c3ccccc3c(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)cc3)c3ccccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.46
KMT2A Q03164 10/20 0.46
ALDH1A1 P00352 8/20 0.46
MAPT P10636 8/20 0.46
HPGD P15428 8/20 0.46
KDM4E B2RXH2 6/20 0.46
RXFP1 Q9HBX9 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP2C19 P33261 1/20 0.46
NTSR1 P30989 1/20 0.44
LMNA P02545 2/20 0.43
GLA P06280 1/20 0.43
BRD4 O60885 1/20 0.39
ADORA1 P30542 5/20 0.39
ADORA2A P29274 3/20 0.39
ADORA3 P0DMS8 3/20 0.38
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24098238 0.95 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24108475 0.93 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21881902 0.93 L3MBTL1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24226052 0.88 L3MBTL1 (0.37) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL21803702 0.88 L3MBTL1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21881776 0.88 L3MBTL1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25791973 0.87 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21881914 0.86 L3MBTL1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18893073 0.86 ACHE (0.37) MAPTLMNA
SCHEMBL22019488 0.86 ACHE (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885ALDH1A1 887/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885ALDH1A1 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.